Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?-Reference-Cited by-同舟云学术

Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?

Published:2018-10 Issue: Volume:124 Page:219-226
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Merino Lara Tomas,Helou Joelle,Poon Ian,Sahgal Arjun,Chung Hans T.,Chu William,Soliman Hany,Ung Yee,Verma Sunil,Cheema Parneet,Cheng Susanna,Khanna Suneil,Erler Darby,Zhang Liying,Cheung Patrick

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline;Videtic;Pract. Radiat. Oncol.,2017

2. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice;Timmerman;J. Clin. Oncol.,2014

3. Radical irradiation of extracranial oligometastases;Salama;J. Clin. Oncol.,2014

4. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial;Iyengar;JAMA Oncol.,2017

5. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol.,2016

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

2. Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors;JAMA Oncology;2024-07-01

3. Clinical outcomes of multisite moderate to high dose radiotherapy for patients with metastatic melanoma;Precision Radiation Oncology;2024-03-24

4. Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma;Cancer Research and Treatment;2024-01-15

5. Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients;World Journal of Surgical Oncology;2023-11-25